Patent · US Active

Combination therapies employing GITR binding molecules

US8591886B2 · kind B2 · utility

104Cited by
48References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2008
Grant dateNov 26, 2013
Priority date—
Expiry dateJul 11, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides combination therapies that employ a GITR binding molecule in combination with one or more additional agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.